ArticleHaematologica2022

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001).

Sarah K Tasian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.